Chorus Aviation (CHR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
27 Jan, 2026Executive summary
Q3 2024 results reflect a strengthening balance sheet, reliable earnings from aviation services, and strong free cash flow of $32.4 million, with progress on the RAL segment sale expected to close by year-end 2024.
Net income from continuing operations was $19.8 million; adjusted earnings available to common shareholders were $11.9 million.
Focus is shifting to share price, shareholder returns, and strengthening core businesses, with a renewed NCIB announced.
Financial highlights
Adjusted EBITDA for Q3 was $53.9 million, with year-to-date at $158.9 million.
Free cash flow for Q3 was $32.4 million, and $91.3 million for the nine months.
Adjusted earnings per share from continuing operations was $0.06 for the quarter; pro forma adjusted EPS would be $0.08 for Q3 and $0.25 year-to-date, reflecting the RAL sale.
Outlook and guidance
The RAL segment sale is on track to close by year-end 2024, expected to eliminate $1.7 billion in financings and substantially all corporate debt.
Pro forma leverage ratio is projected at 1.5, down from the current 3.0, providing significant financial flexibility.
Jazz’s fixed margin under the CPA is forecasted at $60.9 million for 2024, $59.6 million for 2025, and $43.9 million for 2026.
Voyager revenue growth is expected to continue through Q4 and into 2025.
Latest events from Chorus Aviation
- Net income and adjusted EPS surged; dividend up 38%; buybacks and acquisitions announced.CHR
Q4 202513 Feb 2026 - $1.9B leasing segment sale cuts debt, boosts liquidity, and pivots to aviation services growth.CHR
M&A Announcement2 Feb 2026 - RAL segment sale and strong Q2 results set up for lower debt and future growth.CHR
Q2 20241 Feb 2026 - Leasing segment sale cut leverage to 1.4 and boosted cash flow, with strong Voyager and Jazz results.CHR
Q4 202423 Dec 2025 - Q1 2025 net income and EBITDA rose, driven by Voyageur growth and capital returns.CHR
Q1 202526 Nov 2025 - Strong Q2 with higher earnings, new dividend, Elisen acquisition, and defense sector growth.CHR
Q2 202523 Nov 2025 - Adjusted EPS and free cash flow rose, with strategic capital moves despite lower net income.CHR
Q3 202513 Nov 2025